)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Medikit
Medikit (7749) investor relations material
Medikit Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2027 earnings summary12 Nov, 2026
Executive summary
H1 FY2027 net sales rose 6.9% YoY to ¥12,740.5m; operating profit increased 10.6% to ¥2,480.8m and net profit rose 8.4% to ¥1,464.5m.
Comprehensive income reached ¥1,773.1m, up from ¥1,210.8m YoY, supported by gains in available-for-sale securities.
Financial highlights
Gross profit was ¥4,843.5m versus ¥4,580.1m; SG&A was ¥2,362.7m versus ¥2,337.1m for the six months ended September 30, 2026.
Ordinary profit increased 9.6% YoY to ¥2,557.7m; profit attributable to owners of parent rose 8.4% to ¥1,464.5m.
Operating cash flow was ¥1,363.4m, down from ¥2,472.2m YoY; cash and cash equivalents ended the period at ¥15,775.2m.
Outlook and guidance
FY2027 forecast: net sales ¥25,800m (+8.5% YoY), operating profit ¥4,300m (+0.6%), ordinary profit ¥4,400m (-1.9%), and net profit ¥2,850m (-5.2%).
Forecast basic EPS is ¥196.73; full-year forecast unchanged from the latest announcement.
Forecast dividends are ¥50 per share at both interim and year-end, totaling ¥100 per share; dividend forecast unchanged.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Medikit
- Strong quarterly growth in sales and profit, with robust margins and high equity ratio.7749
Q1 2027 - Revenue up 4.1% but profits down; strong balance sheet and ongoing investment in growth.7749Q1 2025
- Revenue up 4.1% year-over-year, but profit margins declined amid rising costs and market shifts.7749Q2 2025
- Revenue up 2.9% year-over-year, but profit outlook remains cautious amid industry headwinds.7749Q3 2025
- Sales rose 3.2% YoY, but profits dipped; FY2026 outlook sees higher sales and dividends.7749Q4 2025
- Sales and profits rose modestly, with strong cash flow and higher dividends forecast.7749Q2 2026
- Sales rose but profits slipped; full-year outlook sees stable sales and strong financial position.7749Q1 2026
- Sales up 5.4% YoY, profits slightly down, strong cash flow, and higher comprehensive income.7749Q4 2026
- Nine-month sales and profits rose, with full-year guidance showing steady sales but lower profit.7749Q3 2026
Next Medikit earnings date
Q3 202710 Feb, 2027
Medikit
Next Medikit earnings date
Q3 202710 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)